Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Cote d'Ivoire: a trial-based analysis

Y. Yazdanpanah, E. Losina, X. Anglaret, S.J. Goldie, R.P. Walensky, M.C. Weinstein, S. Toure, H.E. Smith, J.E. Kaplan, K.A. Freedberg and For The Global Aids Policy Model Investigators
Additional contact information
Y. Yazdanpanah: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Published in AIDS. Official journal of the international AIDS Society, 2005, 19 ((12)), pp.1299-1308

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-00201936

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().